Venofer

DRUG5 trials

Sponsors

American Regent, Inc., Hospital Universitari Vall d'Hebron Research Institute, Azad Pharma AG, Fox Chase Cancer Center

Conditions

AnemiaHeathy VolunteersLiposomated IronParenteral Iron TherapyY-de-Roux Gastric By-Pass

Phase 1

Bioequivalence Study Comparing Single Dose of Ferrinemia® Injection With a Single Dose of Venofer® Injection in Healthy Male Volunteers

CompletedNCT03093883

Azad Pharma AGHeathy Volunteers

Start: 2017-03-13End: 2018-06-26Updated: 2018-07-05

Phase 2

Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients

CompletedNCT00721188

American Regent, Inc.Anemia

Start: 2006-01-31End: 2010-01-31Updated: 2018-02-20

Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

RecruitingNCT05800600

Fox Chase Cancer CenterAnemia

Start: 2023-03-15End: 2028-02-01Target: 34Updated: 2026-05-22

Phase 3

Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia

CompletedNCT00236977

American Regent, Inc.Anemia

Start: 2003-08-31End: 2004-10-31Updated: 2020-10-06

Phase 4

The Use of Liposomated Iron After Bariatric Surgery in Patients That Are Receiving Parentheral Therapy With Iron

CompletedNCT02390921

Hospital Universitari Vall d'Hebron Research InstituteLiposomated Iron, Parenteral Iron Therapy, Y-de-Roux Gastric By-Pass

Start: 2015-02-28End: 2015-11-30Updated: 2017-04-12